Click for best price
TB Vaccines Market Size, Share 2023
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Gu?rin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
This report aims to provide a comprehensive presentation of the global market for TB Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Vaccines. This report contains market size and forecasts of TB Vaccines in global, including the following market information:
Global TB Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global TB Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five TB Vaccines companies in 2022 (%)
The global TB Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immunotherapeutic Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of TB Vaccines include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the TB Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global TB Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TB Vaccines Market Segment Percentages, by Type, 2022 (%)
Immunotherapeutic Vaccines
Booster Vaccines
Others
Global TB Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TB Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Private Clinics
Research Institutes
Global TB Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global TB Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies TB Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies TB Vaccines revenues share in global market, 2022 (%)
Key companies TB Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies TB Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Outline of Major Chapters:
Chapter 1: Introduces the definition of TB Vaccines, market overview.
Chapter 2: Global TB Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of TB Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global TB Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
TB Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 TB Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global TB Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global TB Vaccines Overall Market Size
2.1 Global TB Vaccines Market Size: 2022 VS 2029
2.2 Global TB Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global TB Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top TB Vaccines Players in Global Market
3.2 Top Global TB Vaccines Companies Ranked by Revenue
3.3 Global TB Vaccines Revenue by Companies
3.4 Global TB Vaccines Sales by Companies
3.5 Global TB Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 TB Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers TB Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 TB Vaccines Players in Global Market
3.8.1 List of Global Tier 1 TB Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 TB Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global TB Vaccines Market Size Markets, 2022 & 2029
4.1.2 Immunotherapeutic Vaccines
4.1.3 Booster Vaccines
4.1.4 Others
4.2 By Type - Global TB Vaccines Revenue & Forecasts
4.2.1 By Type - Global TB Vaccines Revenue, 2018-2023
4.2.2 By Type - Global TB Vaccines Revenue, 2024-2029
4.2.3 By Type - Global TB Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global TB Vaccines Sales & Forecasts
4.3.1 By Type - Global TB Vaccines Sales, 2018-2023
4.3.2 By Type - Global TB Vaccines Sales, 2024-2029
4.3.3 By Type - Global TB Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global TB Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global TB Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Private Clinics
5.1.4 Research Institutes
5.2 By Application - Global TB Vaccines Revenue & Forecasts
5.2.1 By Application - Global TB Vaccines Revenue, 2018-2023
5.2.2 By Application - Global TB Vaccines Revenue, 2024-2029
5.2.3 By Application - Global TB Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global TB Vaccines Sales & Forecasts
5.3.1 By Application - Global TB Vaccines Sales, 2018-2023
5.3.2 By Application - Global TB Vaccines Sales, 2024-2029
5.3.3 By Application - Global TB Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global TB Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global TB Vaccines Market Size, 2022 & 2029
6.2 By Region - Global TB Vaccines Revenue & Forecasts
6.2.1 By Region - Global TB Vaccines Revenue, 2018-2023
6.2.2 By Region - Global TB Vaccines Revenue, 2024-2029
6.2.3 By Region - Global TB Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global TB Vaccines Sales & Forecasts
6.3.1 By Region - Global TB Vaccines Sales, 2018-2023
6.3.2 By Region - Global TB Vaccines Sales, 2024-2029
6.3.3 By Region - Global TB Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America TB Vaccines Revenue, 2018-2029
6.4.2 By Country - North America TB Vaccines Sales, 2018-2029
6.4.3 US TB Vaccines Market Size, 2018-2029
6.4.4 Canada TB Vaccines Market Size, 2018-2029
6.4.5 Mexico TB Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe TB Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe TB Vaccines Sales, 2018-2029
6.5.3 Germany TB Vaccines Market Size, 2018-2029
6.5.4 France TB Vaccines Market Size, 2018-2029
6.5.5 U.K. TB Vaccines Market Size, 2018-2029
6.5.6 Italy TB Vaccines Market Size, 2018-2029
6.5.7 Russia TB Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries TB Vaccines Market Size, 2018-2029
6.5.9 Benelux TB Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia TB Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia TB Vaccines Sales, 2018-2029
6.6.3 China TB Vaccines Market Size, 2018-2029
6.6.4 Japan TB Vaccines Market Size, 2018-2029
6.6.5 South Korea TB Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia TB Vaccines Market Size, 2018-2029
6.6.7 India TB Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America TB Vaccines Revenue, 2018-2029
6.7.2 By Country - South America TB Vaccines Sales, 2018-2029
6.7.3 Brazil TB Vaccines Market Size, 2018-2029
6.7.4 Argentina TB Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa TB Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa TB Vaccines Sales, 2018-2029
6.8.3 Turkey TB Vaccines Market Size, 2018-2029
6.8.4 Israel TB Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia TB Vaccines Market Size, 2018-2029
6.8.6 UAE TB Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck & Co.,Inc
7.1.1 Merck & Co.,Inc Company Summary
7.1.2 Merck & Co.,Inc Business Overview
7.1.3 Merck & Co.,Inc TB Vaccines Major Product Offerings
7.1.4 Merck & Co.,Inc TB Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Merck & Co.,Inc Key News & Latest Developments
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur TB Vaccines Major Product Offerings
7.2.4 Sanofi Pasteur TB Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Pasteur Key News & Latest Developments
7.3 Japan BCG Laboratory
7.3.1 Japan BCG Laboratory Company Summary
7.3.2 Japan BCG Laboratory Business Overview
7.3.3 Japan BCG Laboratory TB Vaccines Major Product Offerings
7.3.4 Japan BCG Laboratory TB Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Japan BCG Laboratory Key News & Latest Developments
7.4 China National Biotec Group
7.4.1 China National Biotec Group Company Summary
7.4.2 China National Biotec Group Business Overview
7.4.3 China National Biotec Group TB Vaccines Major Product Offerings
7.4.4 China National Biotec Group TB Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 China National Biotec Group Key News & Latest Developments
7.5 Serum Institute
7.5.1 Serum Institute Company Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute TB Vaccines Major Product Offerings
7.5.4 Serum Institute TB Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute Key News & Latest Developments
7.6 India Pvt. Ltd
7.6.1 India Pvt. Ltd Company Summary
7.6.2 India Pvt. Ltd Business Overview
7.6.3 India Pvt. Ltd TB Vaccines Major Product Offerings
7.6.4 India Pvt. Ltd TB Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 India Pvt. Ltd Key News & Latest Developments
7.7 InterVax Ltd
7.7.1 InterVax Ltd Company Summary
7.7.2 InterVax Ltd Business Overview
7.7.3 InterVax Ltd TB Vaccines Major Product Offerings
7.7.4 InterVax Ltd TB Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 InterVax Ltd Key News & Latest Developments
7.8 GreenSignal
7.8.1 GreenSignal Company Summary
7.8.2 GreenSignal Business Overview
7.8.3 GreenSignal TB Vaccines Major Product Offerings
7.8.4 GreenSignal TB Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 GreenSignal Key News & Latest Developments
7.9 Bio Pharma Limited
7.9.1 Bio Pharma Limited Company Summary
7.9.2 Bio Pharma Limited Business Overview
7.9.3 Bio Pharma Limited TB Vaccines Major Product Offerings
7.9.4 Bio Pharma Limited TB Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Bio Pharma Limited Key News & Latest Developments
7.10 Statens Serum Institut
7.10.1 Statens Serum Institut Company Summary
7.10.2 Statens Serum Institut Business Overview
7.10.3 Statens Serum Institut TB Vaccines Major Product Offerings
7.10.4 Statens Serum Institut TB Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Statens Serum Institut Key News & Latest Developments
8 Global TB Vaccines Production Capacity, Analysis
8.1 Global TB Vaccines Production Capacity, 2018-2029
8.2 TB Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global TB Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 TB Vaccines Supply Chain Analysis
10.1 TB Vaccines Industry Value Chain
10.2 TB Vaccines Upstream Market
10.3 TB Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 TB Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of TB Vaccines in Global Market
Table 2. Top TB Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global TB Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global TB Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global TB Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global TB Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers TB Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers TB Vaccines Product Type
Table 9. List of Global Tier 1 TB Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 TB Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global TB Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global TB Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global TB Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global TB Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global TB Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global TB Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global TB Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global TB Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global TB Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global TB Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global TB Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global TB Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global TB Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global TB Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global TB Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America TB Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America TB Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America TB Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America TB Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe TB Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe TB Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe TB Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe TB Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia TB Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia TB Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia TB Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia TB Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America TB Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America TB Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America TB Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America TB Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa TB Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa TB Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa TB Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa TB Vaccines Sales, (K Units), 2024-2029
Table 46. Merck & Co.,Inc Company Summary
Table 47. Merck & Co.,Inc TB Vaccines Product Offerings
Table 48. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck & Co.,Inc Key News & Latest Developments
Table 50. Sanofi Pasteur Company Summary
Table 51. Sanofi Pasteur TB Vaccines Product Offerings
Table 52. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Sanofi Pasteur Key News & Latest Developments
Table 54. Japan BCG Laboratory Company Summary
Table 55. Japan BCG Laboratory TB Vaccines Product Offerings
Table 56. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Japan BCG Laboratory Key News & Latest Developments
Table 58. China National Biotec Group Company Summary
Table 59. China National Biotec Group TB Vaccines Product Offerings
Table 60. China National Biotec Group TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. China National Biotec Group Key News & Latest Developments
Table 62. Serum Institute Company Summary
Table 63. Serum Institute TB Vaccines Product Offerings
Table 64. Serum Institute TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Serum Institute Key News & Latest Developments
Table 66. India Pvt. Ltd Company Summary
Table 67. India Pvt. Ltd TB Vaccines Product Offerings
Table 68. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. India Pvt. Ltd Key News & Latest Developments
Table 70. InterVax Ltd Company Summary
Table 71. InterVax Ltd TB Vaccines Product Offerings
Table 72. InterVax Ltd TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. InterVax Ltd Key News & Latest Developments
Table 74. GreenSignal Company Summary
Table 75. GreenSignal TB Vaccines Product Offerings
Table 76. GreenSignal TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. GreenSignal Key News & Latest Developments
Table 78. Bio Pharma Limited Company Summary
Table 79. Bio Pharma Limited TB Vaccines Product Offerings
Table 80. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Bio Pharma Limited Key News & Latest Developments
Table 82. Statens Serum Institut Company Summary
Table 83. Statens Serum Institut TB Vaccines Product Offerings
Table 84. Statens Serum Institut TB Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Statens Serum Institut Key News & Latest Developments
Table 86. TB Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global TB Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global TB Vaccines Production by Region, 2018-2023 (K Units)
Table 89. Global TB Vaccines Production by Region, 2024-2029 (K Units)
Table 90. TB Vaccines Market Opportunities & Trends in Global Market
Table 91. TB Vaccines Market Drivers in Global Market
Table 92. TB Vaccines Market Restraints in Global Market
Table 93. TB Vaccines Raw Materials
Table 94. TB Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical TB Vaccines Downstream
Table 96. TB Vaccines Downstream Clients in Global Market
Table 97. TB Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. TB Vaccines Segment by Type in 2022
Figure 2. TB Vaccines Segment by Application in 2022
Figure 3. Global TB Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global TB Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global TB Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. TB Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by TB Vaccines Revenue in 2022
Figure 9. By Type - Global TB Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global TB Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global TB Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global TB Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global TB Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global TB Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global TB Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global TB Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global TB Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global TB Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global TB Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global TB Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America TB Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America TB Vaccines Sales Market Share, 2018-2029
Figure 23. US TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe TB Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe TB Vaccines Sales Market Share, 2018-2029
Figure 28. Germany TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia TB Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia TB Vaccines Sales Market Share, 2018-2029
Figure 37. China TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America TB Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America TB Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa TB Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa TB Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE TB Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global TB Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production TB Vaccines by Region, 2022 VS 2029
Figure 54. TB Vaccines Industry Value Chain
Figure 55. Marketing Channels
